Study of Ebola Virus Disease Survivors in Guinea
Overview
Authors
Affiliations
Background: There is a paucity of data regarding health consequences of Ebola virus disease among survivors.
Methods: We surveyed 105 Ebola virus disease survivors postdischarge from an Ebola treatment unit in Guinea using a standard data collection form. Patients rated recovery as the percentage of improvement in functional status, where 0% represents "unable to perform" and 100% represents "able to perform at prior level."
Results: The mean ± standard deviation time interval between hospital discharge and administration of questionnaire was 103.5 ± 47.9 days in 105 survivors. Anorexia was reported by 103 patients, with varying severity levels: mild (n = 33), moderate (n = 65), or severe (n = 5). Reported pain according to site was chest (30.7%), joint (86.7%), muscle (26.7%), and back (45.7%), among others. Recovery in functional status was graded as mild (10%-30%) (n = 2 [1.9%]), moderate (40%-70%) (n = 52 [50.0%]), and excellent (80%-100%) (n = 50 [48.1%]). Severity of arthralgia (R(2) = 0.09; P = .008) was directly associated with lower recovery in functional status in multivariate analysis.
Conclusions: Ebola virus disease survivors frequently reported anorexia and arthralgia. Severity of arthralgia was related to lower functional recovery. There may be a role for focused screening and intervention for symptoms identified in this study of survivors.
Systematic Review and Meta-Analysis of Female Reproductive Health Following Ebola Virus Disease.
Drogy M, Glezer C, Engel E, Bond N, Pickett K, Shaffer J Am J Trop Med Hyg. 2024; 112(3):663-673.
PMID: 39689367 PMC: 11884292. DOI: 10.4269/ajtmh.23-0709.
Bates J, Kamara A, Bereteh M, Barrera D, Moses L, Sheriff A PLOS Glob Public Health. 2024; 4(11):e0003421.
PMID: 39495749 PMC: 11534246. DOI: 10.1371/journal.pgph.0003421.
Non-Ebola Filoviruses: Potential Threats to Global Health Security.
Munyeku-Bazitama Y, Edidi-Atani F, Takada A Viruses. 2024; 16(8).
PMID: 39205153 PMC: 11359311. DOI: 10.3390/v16081179.
Mandizadza O, Phebeni R, Ji C BMC Public Health. 2024; 24(1):1511.
PMID: 38840082 PMC: 11155043. DOI: 10.1186/s12889-024-19013-8.
Mudalegundi S, Ross R, Larbelee J, Amegashie F, Dolo R, Prakalapakorn G Ophthalmol Sci. 2022; 3(2):100238.
PMID: 36582215 PMC: 9792389. DOI: 10.1016/j.xops.2022.100238.